HMB is produced naturally in our bodies during the metabolism of the essential amino acid leucine. While many of HMB’s ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

The international formula was designed to deliver all the benefits of the US formula while meeting regulatory requirements ...